Characterization of intraocular pressure responses of the Tibetan monkey (Macaca Thibetana)

Molecular Vision

Volumn 17, Issue , 2011, Pages 1405-1413

  Liu, Guo ^a,b   Zeng, Tao ^c   Yu, Wenhan ^a,b   Yan, Naihong ^a   Wang, Hongxing ^c   Cai, Su ping ^a   Pang, Iok Hou ^d   Liu, Xuyang ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c Sichuan Academy of Medical Sciences   (China)

^d ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; NAPHAZOLINE; SPIRADOLINE; TIMOLOL; TRAVOPROST;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DISEASE MODEL; FEEDING BEHAVIOR; FEMALE; GENERAL ANESTHESIA; GLAUCOMA; INTRAOCULAR PRESSURE; MACACA; MALE; MEDICAL RESEARCH; NONHUMAN; OCULOPLETHYSMOGRAPHY; PRESSURE MEASUREMENT; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CIRCADIAN RHYTHM; CLOPROSTENOL; EYE; GLAUCOMA; INTRAOCULAR PRESSURE; MACACA; MALE; MODELS, ANIMAL; NAPHAZOLINE; PYRROLIDINES; TIMOLOL; TONOMETRY, OCULAR;

EID: 79959241879     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80:389-393. [PMID: 8695555]
2. AGIS Investigators. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000; 130:429-440. [PMID: 11024415]
3. CNTGS Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998; 126:487-497. [PMID:9780093]
4. Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, Mills RP. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001; 108:1943-1953. [PMID: 11713061]
5. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK, Wilson MR, Gordon MO. The ocular hypertension treatment study - a randomized trial determines that topcial ocular hypotensive medication delays or prevents the onset of primary open angle glaucoma. Arch Ophthalmol 2002; 120:701-713. [PMID: 12049574]
6. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003; 121:48-56. [PMID: 12523884]
7. Pang I-H, Clark AF. Outflow signaling mechanisms and new therapeutic strategies for the control of intraocular pressure. In: Civan MM, Benos DJ, Simon SA, editors. The Eye's Aqueous Humor. New York: Academic Press; 2008. p. 422-464.
8. Pang I-H, Clark AF. Non-primate models for glaucoma retinopathy and optic neuropathy. In: Pang IH, Clark AF, editors. Animal Models of Retinal Diseases. New York: Humana Press; 2010. p. 139-164.
9. John SW, Smith RS, Savinova OV, Hawes NL, Chang B, Turnbull D, Davisson M, Roderick TH, Heckenlively JR. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 1998; 39:951-962.[PMID: 9579474]
10. Shepard AR, Millar JC, Pang I-H, Jacobson N, Wang WH, Clark AF. Adenoviral gene transfer of active human transforming growth factor-2 elevates intraocular pressure and reduces outflow facility in rodent eyes. Invest Ophthalmol Vis Sci 2010; 51:2067-2076. [PMID: 19959644]
11. Wang WH, McNatt LG, Pang I-H, Millar JC, Hellberg PE, Hellberg MH, Steely HT, Rubin JS, Fingert JH, Sheffield VC, Stone EM, Clark AF. Increased expression of the Wnt antagonist sFRP1 in glaucoma and its regulation of intraocular pressure. J Clin Invest 2008; 118:1056-1064.[PMID: 18274669]
12. Moore TT, Potter DE. Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation. Exp Eye Res 2001; 73:167-178. [PMID: 11446767]
13. Yu W, Cao G, Qiu J, Liu X, Ma J, Li N, Yu M, Yan N, Chen L, Pang I-H. Evaluation of monkey intraocular pressure by rebound tonometer. Mol Vis 2009; 15:2196-2201. [PMID:19898690]
14. Pang I-H, Clark AF. IOP as a target-inflow and outflow pathways. In: Yorio T, Clark AF, Wax MB. Editors. Ocular therapeutics: an eye on new discoveries. New York: Academic Press; 2008. p. 45-67.
15. Bito LZ, Merritt SQ, DeRousseau CJ. Intraocular pressure of rhesus monkeys (Macaca mulatta). I. An initial survey of two free-breeding colonies. Invest Ophthalmol Vis Sci 1979; 18:785-793. [PMID: 110720]
16. Camras CB, Podos SM, Rosenthal JS, Lee PY, Severin CH. Multiple dosing of prostaglandin F2alpha or epinephrine on cynomolgus monkey eyes. I. Aqueous humor dynamics. Invest Ophthalmol Vis Sci 1987; 28:463-469. [PMID: 3470269]
17. Toris CB. Aqueous humor dynamics I: measurement methods and animal studies. In: Civan M, editor. The eye's aqueous humor. 2nd edition. London: Academic Press; 2008. p.193-229.
18. Groves C. Macaca thibetana. In: Wilson DE, Reeder DM, editors. Mammal Species of the World. 3rd edition. Baltimore: Johns Hopkins University Press; 2005. p.164.
19. Russell KR, Moore TT, Potter DE. Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonsits. Neuropeptides 2001; 35:232-237. [PMID:12030807]
20. Ogidigben MJ, Chu TC, Potter DE. Naphazoline-induced neuroendocrine changes: increases in ANP and cGMP levels, but suppression of NE, 3H-NE, and cAMP levels in rabbit eyes. Pharmacology 2002; 65:155-161. [PMID: 12037379]
21. Liu JH, Kripke DF, Hoffman RE, Twa MD, Loving RT, Rex KM, Gupta N, Weinreb RN. Nocturnal elevation of intraocular pressure in young adults. Invest Ophthalmol Vis Sci 1998; 39:2707-2712. [PMID: 9856781]
22. Liu JH, Kripke DF, Twa MD, Hoffman RE, Mansberger SL, Rex KM, Girkin CA, Weinreb RN. Twenty-four-hour pattern of intraocular pressure in the aging population. Invest Ophthalmol Vis Sci 1999; 40:2912-2917. [PMID: 10549652]
23. Komaromy AM, Brooks DE, Kubilis PS, Dawson WW, Sapp HL, Jr Nelson G, Collins BR, Sherwood MB. Diurnal intraocular pressure curves in healthy rhesus macaques (Macaca mulatta) and rhesus macaques with normotensive and hypertensive primary open-angle glaucoma. J Glaucoma 1998; 7:128-131. [PMID: 9559500]
24. Wilensky JT. The role of diurnal pressure measurements in the management of open angle glaucoma. Curr Opin Ophthalmol 2004; 15:90-92. [PMID: 15021217]
25. Castejon H, Chiquet C, Savy O, Baguet JP, Khayi H, Tamisier R, Bourdon L, Romanet JP. Effect of acute increase in blood pressure on intraocular pressure in pigs and humans. Invest Ophthalmol Vis Sci 2010; 51:1599-1605. [PMID: 19850831]
26. Hahnenberger RW. Influence of cataleptoid anaesthetic agents on the intraocular pressure in monkeys (Macaca fascicularis). Acta Ophthalmol (Copenh) 1976; 54:491-499. [PMID: 822686]
27. Burke JA, Potter DE. The ocular effects of xylazine in rabbits, cats, and monkeys. J Ocul Pharmacol 1986; 2:9-21. [PMID:3503099]
28. Bunch TJ, Tian B, Seeman JL, Gabelt BT, Lin TL, Kaufman PL. Effect of daily prolonged ketamine anesthesia on intraocular pressure in monkeys. Curr Eye Res 2008; 33:946-953. [PMID: 19085377]
29. Hellberg MR, Sallee VL, Mclaughlin MA, Sharif NA, Desantis L, Dean TR, Zinke PW. Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist. J Ocul Pharmacol Ther 2001; 17:421-432. [PMID: 11765147]
30. Lindén C. Therapeutic potential of prostaglandin analogues in glaucoma. Expert Opin Investig Drugs 2001; 10:679-694. [PMID: 11281818]
31. Camras CB, Bito LZ. Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F2 alpha. Curr Eye Res 1981; 1:205-209. [PMID: 6949676]
32. Serle JB, Podos SM, Kitazawa Y, Wang RF. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes. Jpn J Ophthalmol 1998; 42:95-100. [PMID: 9587840]
33. Lee PY, Podos SM, Serle JB, Camras CB, Severin CH. Intraocular pressure effects of multiple doses of drugs applied to glaucomatous monkey eyes. Arch Ophthalmol 1987; 105:249-252. [PMID: 3813959]
34. Miichi H, Nagataki S. Effects of pilocarpine, salbutamol, and timolol on aqueous humor formation in cynomolgus monkeys. Invest Ophthalmol Vis Sci 1983; 24:1269-1275.[PMID: 6885311]
35. Kiland JA, Gabelt BT, Kaufman PL. Studies on the mechanism of action of timolol and on the effects of suppression and redirection of aqueous flow on outflow facility. Exp Eye Res 2004; 78:639-651. [PMID: 15106944]
36. Nathanson JA. Direct application of a guanylate cyclase activator lowers intraocular pressure. Eur J Pharmacol 1988; 147:155-156. [PMID: 2897308]
37. Stein PJ, Clack JW. Topical application of a cyclic GMP analog lowers IOP in normal and ocular hypertensive rabbits. Invest Ophthalmol Vis Sci 1994; 35:2765-2768. [PMID: 8188470]